Both flow cytometry and immunofluorescence suggested that ischemic stroke induced LCN2 expression in PMN-MDSC in the tumor and promoted the recruitment of PMN-MDSC into the tumor, which may underlie the increased immune suppressive microenvironment of the tumor after stroke. The gene discussed is LCN2; the disease is ischemic stroke.